Epigenomic Reprogramming and Therapeutics Development in High-Grade GliomasStefan R. SwehaDeep Blue (University of Michigan)January 1, 202110.7302/3878Cited by 0SaveCiteExport RISWatch citationsRelated PapersIsocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis|Cancer Cell|2025|21MDB-78. ISOCITRATE DEHYDROGENASE 1 INHIBITION PRIMES GROUP-3 MEDULLOBLASTOMAS FOR CUPROPTOSIS|Neuro-Oncology|2024|0